openPR Logo
Press release

Tissue Engineered Skin Substitutes Market Positive Long-Term Growth Outlook by 2023

06-21-2017 03:44 PM CET | IT, New Media & Software

Press release from: TMR - Research Reports

Tissue Engineered Skin Substitutes Market Positive Long-Term

Tissue Engineered Skin Substitutes Market: Snapshot

The elderly are highly prone to contracting skin diseases such as various forms of ulcers due to their significantly reduced flow of blood and overall immunity against diseases. The number of geriatrics in all nations has been on the rise owing to multiple factors, and a rise in their number is a direct call to action for all related healthcare organizations, products, and services. This includes the tissue engineered skin substitute providers and makes the above the top driver for its market.

Read the Comprehensive Overview of Tissue Engineered Skin Substitutes Market: http://www.transparencymarketresearch.com/tissue-engineered-skin-substitute.html

The number of patients suffering from skin diseases and ulcers is also increasing within younger demographics. The CDC, for instance, stated in 2015 that close to 900,000 people are affected by DVT per year. A large number of patients were additionally being diagnosed with venous diseases per year, further boosting the need for tissue engineered skin substitutes.

The market is, however, restrained by over competitiveness between local manufacturers and their globally prominent counterparts. The local manufacturers can offer tissue engineered skin substitutes at a much lower price than global ones, forcing the latter to drop prices and consequently their profit margins. This will affect the market’s rate of research and development in the long run.

These drivers and restraints are expected to converge to result in a CAGR of 17.2% for the global market of tissue engineered skin substitutes between 2015 and 2023. This market is expected to be valued at US$1.24 bn by the end of 2016, and US$3.87 bn by 2023.

North America Continues to Show Strong Demand for Tissue Engineered Skin Substitutes

The need for tissue engineered skin substitutes in North America has consistently been high over the past few years. It is expected to generate US$1.96 bn in revenue for tissue engineered skin substitute players by 2023. A key reason prompting the use of tissue engineered skin substitutes in North America is the very high prevalence of vascular diseases. The region holds an especially high proportion of the geriatric, diabetic, and obese demographics and thus requires tissue engineered skin substitutes to a higher degree than other major regions.

Europe is another key region for tissue engineered skin substitute players. This region shows a similarly high demand as that shown by North America, although at a smaller revenue cap. The highest demand for tissue engineered skin substitutes at the moment, however, comes from Asia Pacific. The revenue earned by tissue engineered skin substitute providers in this region is expected to progress at a CAGR of 18.3% from 2015 to 2023. Key reasons for the high proliferation of tissue engineered skin substitute players in Asia Pacific is the growing geriatric population in nations such as South Korea and Japan, along with the rapidly increasing investments made by governments into the market.

Tissue Engineered Skin Substitutes to Find Increasing Demand in Treatment of Ulcers

Ulcers have consistently been the leading application segment for tissue engineered skin substitutes. By the end of 2023, nearly US$2.1 bn will be generated by tissue engineered skin substitute players through ulcer treatment alone. This segment is also expected to grow at a robust CAGR of 17.5% within 2015 and 2023.

The same applies to other skin disorders that are growing in prevalence across the globe. Most dermatology organizations such as the ADA have made their predictions, all of which point to a growing number of patients with skin disorders. The ADA, for instance, in 2013, released findings of a study that stated at least one in every five U.S. citizens will suffer from a skin disorder in their lifetime. This makes the development of dermatology solutions such as tissue engineered skin substitutes a matter of high concern.

Request for the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3854

The key manufacturers of tissue engineered skin substitutes include Acelity, Smith & Nephew, Molnlycke, ConVatec, Medtronic, and BSN Medical

About TMR

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Tissue Engineered Skin Substitutes Market Positive Long-Term Growth Outlook by 2023 here

News-ID: 590174 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Tissue

Tissue Towel Market Report 2021: COVID-19 Growth And Change Players are Cascades …
The Tissue Towel Market is rising at a sooner tempo with considerable development charges over the previous couple of years and is estimated that the market will develop considerably within the forecasted period. Looking for More Insights from this Report? Get Free Sample Copy @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=north-america-tissue-towel-market&utm_source=manisha (The sample of this report is readily available on request) This Free report sample includes: • A brief introduction to the research report. • Graphical introduction of the regional
Industry Update: Printed Tissue Paper Market Set New Growth Story | Royal Tissue …
Printed Tissue Paper Market will reach an estimated valuation of USD 651.2 million by 2027, while registering this growth at a rate of 4.80% for the forecast period of 2020 to 2027. FMCG Industry is facing Challenges to adapt to new Delivery and Purchasing Pattern to Ride out the Covid19 Disruption Increasing knowledge concerning sanitation and healthcare is a principal constituent stimulating the market for tissue paper. Furthermore, practice of tissue
Roll Towel Tissue Towel Market 2018 Organized Authoritative Study report By WEPA …
Fior Markets offers a latest published report on Global Roll Towel Tissue Towel Market Growth 2018-2023, providing key insights and giving a competitive advantage to consumers through a detailed report. The researchers have included essential figures associated with the production and consumption forecast for the major regions that the market is separated into consumption forecast by application and production forecast by type. The research study is a source of methodical
Tissue Expanders Market Global Review 2017 to 2026| by Region - North America, L …
According to Fact.MR, the global tissue expanders market is expected to represent a value of over US$ 800 Mn by the end of 2026. Removal of breast attributed to growing cases of breast cancer has led to surge in demand for reconstructing breast. In addition, increasing demand for reconstructing the scalp and forehead skin attributed to skin distinction is expected to contribute towards growth of the global tissue expanders market during
Tissue Expanders Market by Region - North America, Latin America, Europe, Japan, …
Removal of breast attributed to growing cases of breast cancer has led to surge in demand for reconstructing breast. In addition, increasing demand for reconstructing the scalp and forehead skin attributed to skin distinction is expected to contribute towards growth of the global tissue expanders market during the forecast period. Moreover, treatment of cancer diseases leads to severe injuries on neck and face, burns and birth defects. Growing preference for the reconstruction
Soft Tissue Repair Market, by Product Type Fixation Products, Tissue Patch,
According to the European Union government legislature, European government will be spending almost 80 billion Euros on Research and Development to enhance a broad range of research projects. According to American Joint Replacement Registry (AJRR), around 75% increase in hospitals was reported and 41% increase in the number of surgeons from the year 2012 -2015, hence there is an increment of 102% in the number of cases related to joint